| 2025-08-12 |
13D/A |
NAMS / NewAmsterdam Pharma Company N.V. |
Forbion Capital Fund IV Cooperatief U.A. |
10,578,806 |
9.40 |
-4.90 |
| 2025-08-11 |
13D/A |
TRVI / Trevi Therapeutics, Inc. |
New Enterprise Associates 16, L.P. |
15,074,080 |
12.00 |
0.00 |
| 2025-08-08 |
13D/A |
AMRX / Amneal Pharmaceuticals, Inc. |
Patel Chirag K. |
22,180,421 |
7.10 |
1.58 |
| 2025-08-08 |
13D |
PCRX / Pacira BioSciences, Inc. |
Doma Perpetual Capital Management LLC |
2,698,618 |
5.70 |
|
| 2025-08-07 |
13D/A |
EPIX / ESSA Pharma Inc. |
Biotechnology Value Fund L P |
11,668,473 |
24.70 |
33.37 |
| 2025-08-07 |
13D/A |
IMAB / I-Mab - Depositary Receipt (Common Stock) |
CBC Investment I-Mab Ltd |
27,492,595 |
10.40 |
-18.11 |
| 2025-08-06 |
13D/A |
STTK / Shattuck Labs, Inc. |
Redmile Group, LLC |
5,652,660 |
11.80 |
0.49 |
| 2025-08-05 |
13D |
IMAB / I-Mab - Depositary Receipt (Common Stock) |
Everest Medicines Limited |
42,524,716 |
16.10 |
|
| 2025-08-01 |
13D/A |
ALZN / Alzamend Neuro, Inc. |
Ault Milton C Iii |
706,322 |
18.50 |
-77.63 |
| 2025-08-01 |
13D/A |
CVAC / CureVac N.V. |
KfW |
112,841,355 |
50.10 |
-1.18 |
| 2025-08-01 |
13D/A |
SPRY / ARS Pharmaceuticals, Inc. |
Deerfield Mgmt III, L.P. |
7,610,217 |
7.75 |
-11.85 |
| 2025-07-31 |
13D/A |
LRMR / Larimar Therapeutics, Inc. |
Deerfield Private Design Fund III, L.P. |
30,667,474 |
35.81 |
|
| 2025-07-29 |
13D/A |
INDV / Indivior PLC |
Two Seas Capital LP |
11,662,308 |
9.30 |
-3.50 |
| 2025-07-28 |
13D/A |
CELU / Celularity Inc. |
Dragasac Ltd |
14,138,161 |
41.00 |
42.26 |
| 2025-07-28 |
13D/A |
GLPG / Galapagos NV - Depositary Receipt (Common Stock) |
EcoR1 Capital, LLC |
8,714,522 |
13.22 |
11.68 |
| 2025-07-25 |
13D/A |
BFRI / Biofrontera Inc. |
Deutsche Balaton Aktiengesellschaft |
458,884 |
4.86 |
0.00 |
| 2025-07-22 |
13D/A |
SPRY / ARS Pharmaceuticals, Inc. |
Deerfield Mgmt III, L.P. |
8,633,537 |
8.79 |
-11.22 |
| 2025-07-22 |
13D/A |
BMEA / Biomea Fusion, Inc. |
Cormorant Global Healthcare Master Fund, LP |
3,681,664 |
6.46 |
2.53 |
| 2025-07-21 |
13D/A |
EPIX / ESSA Pharma Inc. |
Soleus Capital Master Fund, L.P. |
4,362,026 |
9.80 |
92.84 |
| 2025-07-21 |
13D/A |
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock) |
Panacea Innovation Ltd |
13,950,000 |
25.10 |
4.03 |
| 2025-07-16 |
13D/A |
ONCO / Onconetix, Inc. |
Altos Venture AG |
273,230 |
35.80 |
|
| 2025-07-16 |
13D |
HYPD / Hyperion DeFi, Inc. |
Hyunsu Jung |
500,000 |
9.30 |
|
| 2025-07-15 |
13D/A |
RCUS / Arcus Biosciences, Inc. |
Gilead Sciences Inc |
31,424,760 |
29.70 |
-20.83 |
| 2025-07-15 |
13D/A |
ABVC / ABVC BioPharma, Inc. |
Eugene Jiang |
131,159 |
18.50 |
0.00 |
| 2025-07-14 |
13D/A |
COGT / Cogent Biosciences, Inc. |
Fairmount Funds Management LLC |
14,324,918 |
9.90 |
26.43 |
| 2025-07-14 |
13D/A |
INDV / Indivior PLC |
Two Seas Capital LP |
12,084,677 |
9.70 |
0.10 |
| 2025-07-10 |
13D/A |
RENB / Lunai Bioworks Inc. |
William Anderson Wittekind |
18,133,196 |
8.00 |
0.00 |
| 2025-07-02 |
13D/A |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
435,438 |
8.53 |
0.00 |
| 2025-07-02 |
13D/A |
SPRY / ARS Pharmaceuticals, Inc. |
Deerfield Mgmt III, L.P. |
9,724,508 |
9.90 |
-7.51 |
| 2025-07-01 |
13D/A |
BBIO / BridgeBio Pharma, Inc. |
Viking Global Investors Lp |
18,602,920 |
9.80 |
-15.65 |
| 2025-07-01 |
13D |
TCRT / Alaunos Therapeutics, Inc. |
Postma Robert W |
199,796 |
9.00 |
|
| 2025-07-01 |
13D/A |
RVPH / Reviva Pharmaceuticals Holdings, Inc. |
Vedanta Associates, L.P. |
6,259,806 |
8.70 |
|
| 2025-07-01 |
13D/A |
RVPH / Reviva Pharmaceuticals Holdings, Inc. |
Bhat Laxminarayan |
3,612,384 |
5.20 |
12.95 |
| 2025-06-30 |
13D/A |
BIVI / BioVie Inc. |
Acuitas Group Holdings, LLC |
3,050,394 |
15.80 |
-90.00 |
| 2025-06-27 |
13D |
ZYME / Zymeworks Inc. |
EcoR1 Capital, LLC |
22,970,388 |
30.70 |
29.78 |
| 2025-06-27 |
13D/A |
NATR / Nature's Sunshine Products, Inc. |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
64,167 |
0.35 |
-97.80 |
| 2025-06-26 |
13D/A |
ORGO / Organogenesis Holdings Inc. |
Ades Alan A. |
22,319,836 |
17.60 |
0.00 |
| 2025-06-25 |
13D/A |
SLNCF / Silence Therapeutics plc |
Griffiths Richard Ian |
34,543,302 |
24.40 |
4.95 |
| 2025-06-23 |
13D/A |
CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) |
OrbiMed Israel BioFund GP Limited Partnership |
969,807 |
4.80 |
-47.89 |
| 2025-06-23 |
13D/A |
STOK / Stoke Therapeutics, Inc. |
Blue Horizon Enterprise Ltd |
3,256,181 |
6.00 |
-16.64 |
| 2025-06-23 |
13D/A |
ADXN / Addex Therapeutics Ltd - Depositary Receipt (Common Stock) |
Dyer Timothy Mark |
18,208,437 |
12.94 |
7.98 |
| 2025-06-20 |
13D/A |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
435,438 |
9.99 |
0.00 |
| 2025-06-18 |
13D/A |
INDV / Indivior PLC |
Two Seas Capital LP |
12,072,398 |
9.70 |
1.61 |
| 2025-06-17 |
13D/A |
ELVN / Enliven Therapeutics, Inc. |
Orbimed Advisors Llc |
7,918,163 |
13.40 |
0.00 |
| 2025-06-17 |
13D/A |
BHC / Bausch Health Companies Inc. |
Paulson & Co. Inc. |
32,791,702 |
8.90 |
24.03 |
| 2025-06-16 |
13D |
ARVN / Arvinas, Inc. |
Logos Global Management LP |
4,800,000 |
6.40 |
|
| 2025-06-16 |
13D/A |
CVAC / CureVac N.V. |
dievini Hopp BioTech holding GmbH & Co KG |
82,373,544 |
36.70 |
-1.80 |
| 2025-06-16 |
13D/A |
MEHCQ / Chrome Holding Co. |
ABeeC 2.0, LLC |
5,722,832 |
22.00 |
1.12 |
| 2025-06-13 |
13D/A |
LTRN / Lantern Pharma Inc. |
BIOS Fund I, LP |
1,075,952 |
9.98 |
|
| 2025-06-13 |
13D/A |
PRLD / Prelude Therapeutics Incorporated |
Baker Bros. Advisors Lp |
10,269,968 |
23.50 |
0.46 |
